HNRNPR Variants that Impair Homeobox Gene Expression Drive Developmental Disorders in Humans.


Journal

American journal of human genetics
ISSN: 1537-6605
Titre abrégé: Am J Hum Genet
Pays: United States
ID NLM: 0370475

Informations de publication

Date de publication:
06 06 2019
Historique:
received: 17 10 2018
accepted: 25 03 2019
pubmed: 14 5 2019
medline: 12 3 2020
entrez: 14 5 2019
Statut: ppublish

Résumé

The heterogeneous nuclear ribonucleoprotein (HNRNP) genes code for a set of RNA-binding proteins that function primarily in the spliceosome C complex. Pathogenic variants in these genes can drive neurodegeneration, through a mechanism involving excessive stress-granule formation, or developmental defects, through mechanisms that are not known. Here, we report four unrelated individuals who have truncating or missense variants in the same C-terminal region of hnRNPR and who have multisystem developmental defects including abnormalities of the brain and skeleton, dysmorphic facies, brachydactyly, seizures, and hypoplastic external genitalia. We further identified in the literature a fifth individual with a truncating variant. RNA sequencing of primary fibroblasts reveals that these HNRNPR variants drive significant changes in the expression of several homeobox genes, as well as other transcription factors, such as LHX9, TBX1, and multiple HOX genes, that are considered fundamental regulators of embryonic and gonad development. Higher levels of retained intronic HOX sequences and lost splicing events in the HOX cluster are observed in cells carrying HNRNPR variants, suggesting that impaired splicing is at least partially driving HOX deregulation. At basal levels, stress-granule formation appears normal in primary and transfected cells expressing HNRNPR variants. However, these cells reveal profound recovery defects, where stress granules fail to disassemble properly, after exposure to oxidative stress. This study establishes an essential role for HNRNPR in human development and points to a mechanism that may unify other "spliceosomopathies" linked to variants that drive multi-system congenital defects and are found in hnRNPs.

Identifiants

pubmed: 31079900
pii: S0002-9297(19)30120-X
doi: 10.1016/j.ajhg.2019.03.024
pmc: PMC6556882
pii:
doi:

Substances chimiques

HNRNPR protein, human 0
Heterogeneous-Nuclear Ribonucleoproteins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1040-1059

Subventions

Organisme : European Research Council
ID : 638290
Pays : International

Informations de copyright

Copyright © 2019 American Society of Human Genetics. Published by Elsevier Inc. All rights reserved.

Références

Brain Res. 2012 Jun 26;1462:61-80
pubmed: 22445064
Pediatr Cardiol. 2015 Oct;36(7):1400-10
pubmed: 25860641
Sci Rep. 2016 Jan 20;6:19197
pubmed: 26786475
Drug Metab Dispos. 1996 Apr;24(4):436-46
pubmed: 8801059
Hum Mutat. 2015 Oct;36(10):1009-1014
pubmed: 26173930
Genome Biol. 2010;11(10):R106
pubmed: 20979621
Cell. 2009 Apr 3;137(1):146-58
pubmed: 19345193
Nucleic Acids Res. 2019 Jan 8;47(D1):D886-D894
pubmed: 30371827
Nat Methods. 2014 Apr;11(4):361-2
pubmed: 24681721
Mol Cell. 2013 Jun 6;50(5):613-23
pubmed: 23746349
Bioinformatics. 2015 Jan 15;31(2):166-9
pubmed: 25260700
Nat Protoc. 2016 Jan;11(1):1-9
pubmed: 26633127
Cell. 1977 May;11(1):127-38
pubmed: 872217
Hum Mol Genet. 2018 Jun 1;27(11):1847-1857
pubmed: 29509905
Mol Cell Proteomics. 2014 Feb;13(2):397-406
pubmed: 24309898
Hum Reprod Update. 1999 Sep-Oct;5(5):535-45
pubmed: 10582791
Science. 1986 Mar 28;231(4745):1534-9
pubmed: 3952495
Genomics. 1994 Oct;23(3):669-84
pubmed: 7851896
Am J Med Genet A. 2017 Oct;173(10):2680-2689
pubmed: 28815871
Cell. 2016 Jan 28;164(3):487-98
pubmed: 26777405
Bioinformatics. 2014 Sep 1;30(17):2501-2
pubmed: 24825614
Genome Biol. 2014;15(12):550
pubmed: 25516281
Am J Med Genet A. 2012 Jul;158A(7):1633-40
pubmed: 22678713
PLoS One. 2015 Apr 29;10(4):e0123380
pubmed: 25923916
Nat Commun. 2020 Nov 20;11(1):5918
pubmed: 33219223
Rapid Commun Mass Spectrom. 2007;21(20):3317-22
pubmed: 17879390
Nature. 2000 Feb 24;403(6772):909-13
pubmed: 10706291
Genesis. 2009 Mar;47(3):188-95
pubmed: 19253341
Clin Genet. 2018 Feb;93(2):401-407
pubmed: 28374925
Proc Natl Acad Sci U S A. 2011 Aug 16;108(33):13576-81
pubmed: 21825130
Am J Hum Genet. 2008 Jul;83(1):89-93
pubmed: 18571142
Genet Med. 2016 Sep;18(9):898-905
pubmed: 26795593
Nucleic Acids Res. 2016 Feb 29;44(4):1483-95
pubmed: 26773057
Clin Genet. 2016 Sep;90(3):258-62
pubmed: 26954065
Bioessays. 1998 Jan;20(1):9-19
pubmed: 9504043
Mol Cell Biol. 2010 Jan;30(1):319-32
pubmed: 19884345
J Vis Exp. 2011 Nov 08;(57):
pubmed: 22090023
RNA. 2010 Aug;16(8):1449-62
pubmed: 20584894
J Neurosci. 1999 Jan 15;19(2):783-93
pubmed: 9880598
Cell. 1992 Dec 11;71(6):901-10
pubmed: 1360874
Annu Rev Biochem. 1993;62:289-321
pubmed: 8352591
Nat Rev Genet. 2005 Dec;6(12):893-904
pubmed: 16341070
Cell. 1994 Jul 29;78(2):191-201
pubmed: 7913880
Eur J Hum Genet. 2011 Jan;19(1):102-7
pubmed: 20736978
Cell. 2000 May 12;101(4):435-45
pubmed: 10830170
Proc Natl Acad Sci U S A. 2007 Sep 18;104(38):14994-9
pubmed: 17848526
Nature. 1989 Feb 2;337(6206):464-7
pubmed: 2563568
Nat Methods. 2010 Apr;7(4):248-9
pubmed: 20354512
Mol Genet Metab. 2014 Jan;111(1):4-15
pubmed: 24239177
Drug Metab Dispos. 2005 Dec;33(12):1920-4
pubmed: 16204461
Proc Natl Acad Sci U S A. 2000 Oct 24;97(22):11910-5
pubmed: 11050225
Hum Mutat. 2015 Oct;36(10):928-30
pubmed: 26220891
Trends Cell Biol. 1993 May;3(5):151-5
pubmed: 14731609
Nat Methods. 2015 Apr;12(4):357-60
pubmed: 25751142
Nature. 2013 Mar 28;495(7442):467-73
pubmed: 23455423
Biochim Biophys Acta. 2002 Aug 19;1591(1-3):1-10
pubmed: 12183049
Trends Cell Biol. 2016 Sep;26(9):668-679
pubmed: 27289443
Am J Hum Genet. 2016 Sep 1;99(3):728-734
pubmed: 27545675
Genes Dev. 1998 Mar 1;12(5):679-91
pubmed: 9499403
Hum Genet. 2017 Jul;136(7):821-834
pubmed: 28393272
Lancet. 2003 Oct 25;362(9393):1366-73
pubmed: 14585638
BMC Dev Biol. 2013 Aug 23;13:33
pubmed: 23971992

Auteurs

Floor A Duijkers (FA)

Amsterdam University Medical Centers, University of Amsterdam, Department of Clinical Genetics, Meibergdreef 9, 1105 AZ Amsterdam, the Netherlands.

Andrew McDonald (A)

Amsterdam University Medical Centers, University of Amsterdam, Laboratory Genetic Metabolic Diseases, Amsterdam Gastroenterology and Metabolism, Meibergdreef 9, 1105 AZ Amsterdam, the Netherlands.

Georges E Janssens (GE)

Amsterdam University Medical Centers, University of Amsterdam, Laboratory Genetic Metabolic Diseases, Amsterdam Gastroenterology and Metabolism, Meibergdreef 9, 1105 AZ Amsterdam, the Netherlands.

Marco Lezzerini (M)

Amsterdam University Medical Centers, University of Amsterdam, Laboratory Genetic Metabolic Diseases, Amsterdam Gastroenterology and Metabolism, Meibergdreef 9, 1105 AZ Amsterdam, the Netherlands.

Aldo Jongejan (A)

Amsterdam University Medical Centers, University of Amsterdam, Bioinformatics Laboratory, Meibergdreef 9, 1105 AZ Amsterdam, the Netherlands.

Silvana van Koningsbruggen (S)

Amsterdam University Medical Centers, University of Amsterdam, Department of Clinical Genetics, Meibergdreef 9, 1105 AZ Amsterdam, the Netherlands.

Wendela G Leeuwenburgh-Pronk (WG)

Amsterdam University Medical Centers, University of Amsterdam, Department of Pediatrics, Meibergdreef 9, 1105 AZ Amsterdam, the Netherlands.

Marcin W Wlodarski (MW)

Department of Pediatric Hematology and Oncology, University of Freiburg, D-79106 Freiburg, Germany.

Sébastien Moutton (S)

Institut National de la Santé et de la Recherche Médicale UMR 1231 GAD, Génétique des Anomalies du Dévelopement, Université de Bourgogne-Franche Comté, F-21079 Dijon, France; Fédération Hospitalo-Universitaire Médecine TRANSLationnelle et Anomalies du Développement, Centre Hospitalier Universitaire et Université de Bourgogne-Franche Comté, 21000 Dijon, France; Centre de Génétique et Centre de Référence Anomalies du Développement et Syndromes Malformatifs de l'Inter-région Est, Centre Hospitalier Universitaire Dijon Bourgogne, F-21079 Dijon, France.

Frédéric Tran-Mau-Them (F)

Institut National de la Santé et de la Recherche Médicale UMR 1231 GAD, Génétique des Anomalies du Dévelopement, Université de Bourgogne-Franche Comté, F-21079 Dijon, France; Fédération Hospitalo-Universitaire Médecine TRANSLationnelle et Anomalies du Développement, Centre Hospitalier Universitaire et Université de Bourgogne-Franche Comté, 21000 Dijon, France.

Christel Thauvin-Robinet (C)

Institut National de la Santé et de la Recherche Médicale UMR 1231 GAD, Génétique des Anomalies du Dévelopement, Université de Bourgogne-Franche Comté, F-21079 Dijon, France; Fédération Hospitalo-Universitaire Médecine TRANSLationnelle et Anomalies du Développement, Centre Hospitalier Universitaire et Université de Bourgogne-Franche Comté, 21000 Dijon, France; Centre de Génétique et Centre de Référence Anomalies du Développement et Syndromes Malformatifs de l'Inter-région Est, Centre Hospitalier Universitaire Dijon Bourgogne, F-21079 Dijon, France.

Laurence Faivre (L)

Institut National de la Santé et de la Recherche Médicale UMR 1231 GAD, Génétique des Anomalies du Dévelopement, Université de Bourgogne-Franche Comté, F-21079 Dijon, France.

Kristin G Monaghan (KG)

GeneDx, Gaithersburg, MD 20877, USA.

Thomas Smol (T)

Université de Lille, EA 7364 - RADEME, F-59000 Lille, France; Centre Hospitalier Universitaire Lille, Institut de Génétique Médicale, F-59000 Lille, France.

Odile Boute-Benejean (O)

Université de Lille, EA 7364 - RADEME, F-59000 Lille, France; Centre Hospitalier Universitaire Lille, Institut de Génétique Médicale, F-59000 Lille, France.

Roger L Ladda (RL)

Department of Pediatrics, Penn State Children's Hospital, Hershey, PA 17033, USA.

Susan L Sell (SL)

Department of Pediatrics, Penn State Children's Hospital, Hershey, PA 17033, USA.

Ange-Line Bruel (AL)

Institut National de la Santé et de la Recherche Médicale UMR 1231 GAD, Génétique des Anomalies du Dévelopement, Université de Bourgogne-Franche Comté, F-21079 Dijon, France; Fédération Hospitalo-Universitaire Médecine TRANSLationnelle et Anomalies du Développement, Centre Hospitalier Universitaire et Université de Bourgogne-Franche Comté, 21000 Dijon, France.

Riekelt H Houtkooper (RH)

Amsterdam University Medical Centers, University of Amsterdam, Laboratory Genetic Metabolic Diseases, Amsterdam Gastroenterology and Metabolism, Meibergdreef 9, 1105 AZ Amsterdam, the Netherlands.

Alyson W MacInnes (AW)

Amsterdam University Medical Centers, University of Amsterdam, Laboratory Genetic Metabolic Diseases, Amsterdam Gastroenterology and Metabolism, Meibergdreef 9, 1105 AZ Amsterdam, the Netherlands. Electronic address: a.w.macinnes@amc.nl.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH